1431081-05-8

Basic information

• Product Name: N-(4-methoxycarbonylbenzyl)-1,2,4,9-tetrahydro-3-thia-9-azafluorene-3,3-dioxide
• Synonyms: N-(4-methoxycarbonylbenzyl)-1,2,4,9-tetrahydro-3-thia-9-azafluorene-3,3-dioxide
• CAS NO: 1431081-05-8
• Molecular Weight: 369.441
• Mol File: 1431081-05-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: N-(4-methoxycarbonylbenzyl)-1,2,4,9-tetrahydro-3-thia-9-azafluorene-3,3-dioxide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(4-methoxycarbonylbenzyl)-1,2,4,9-tetrahydro-3-thia-9-azafluorene-3,3-dioxide(1431081-05-8)
• EPA Substance Registry System: N-(4-methoxycarbonylbenzyl)-1,2,4,9-tetrahydro-3-thia-9-azafluorene-3,3-dioxide(1431081-05-8)

Safety Data

• Hazardous Substances Data: 1431081-05-8(Hazardous Substances Data)

Upstream product

• 1072-72-6 Tetrahydrothiopyran-4-one 
• 7076-17-7 1,3,4,5-tetrahydrothiopyrano[4,3-b]indole 
• 2417-72-3 Methyl 4-(bromomethyl)benzoate 
• 96729-81-6 1,2,4,9-tetrahydro-3-thia-9-azafluorene-3,3-dioxide 

Downstream Products

• 1431080-97-5 N-(4-hydroxycarbamoylbenzyl)-1,2,4,9-tetrahydro-3-thia-9-azafluorene-3,3-dioxide 

Relevant articles and documents

HDAC6 INHIBITORS AND USES THEREOF

The present invention relates to Histone deacetylases 6 (HDAC6) inhibitors and compositions containing the same. Methods of treating diseases and conditions wherein inhibition of HDAC6 provides a benefit, like a cell proliferative disease, an autoimmune or inflammatory disorder, a neurodegenerative disease, a viral disease, malaria, or a combination thereof, also are disclosed.